First-line therapy for ovarian cancer with carboplatin followed by paclitaxel-gemcitabine (SCOTROC5): a feasibility study and comparative analysis of the SCOTROC series.

Saved in:
Bibliographic Details
Title: First-line therapy for ovarian cancer with carboplatin followed by paclitaxel-gemcitabine (SCOTROC5): a feasibility study and comparative analysis of the SCOTROC series.
Authors: Agarwal R (AUTHOR), Gourley C (AUTHOR), Perren TJ (AUTHOR), Reed N (AUTHOR), Parkin DE (AUTHOR), Carty K (AUTHOR), Rustin GJS (AUTHOR), Gabra H (AUTHOR), Paul J (AUTHOR), Gore ME (AUTHOR), Kaye SB (AUTHOR), Scottish Gynecological Cancers Trials Group (CORPORATE AUTHOR)
Source: European Journal of Cancer. Jul2010, Vol. 46 Issue 11, p2020-2026. 7p.
Database: Academic Search Ultimate
Description
ISSN:09598049
DOI:10.1016/j.ejca.2010.03.006